Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis

  • Lotte K. Vogel
  • , Mona Saebo
  • , Helle Hoyer
  • , Tine Iskov Kopp
  • , Ulla Vogel
  • , Sine Godiksen
  • , Franz B. Frenzel
  • , Julian Hamfjord
  • , Inger Marie Bowitz-Lothe
  • , Egil Johnson
  • , Elin H. Kure
  • , Vibeke Andersen

Research output: Contribution to journalJournal articleResearchpeer-review

441 Downloads (Orbit)

Abstract

Background & Aims: Inflammation is a major risk factor for development of colorectal cancer (CRC). Prostaglandin synthase cyclooxygenase-2 (COX-2) encoded by the PTGS2 gene is the rate limiting enzyme in prostaglandin synthesis and therefore plays a distinct role as regulator of inflammation. Methods: PTGS2 mRNA levels were determined in intestinal tissues from 85 intestinal adenoma cases, 115 CRC cases, and 17 healthy controls. The functional PTGS2 polymorphisms A-1195G (rs689466), G-765C (rs20417), T8473C (rs5275) were assessed in 200 CRC cases, 991 adenoma cases and 399 controls from the Norwegian KAM cohort. Results: PTGS2 mRNA levels were higher in mild/moderate adenoma tissue compared to morphologically normal tissue from the same individual (P
Original languageEnglish
Article numbere105254
JournalPLOS ONE
Volume9
Issue number8
Number of pages8
ISSN1932-6203
DOIs
Publication statusPublished - 2014

Keywords

  • MULTIDISCIPLINARY
  • INFLAMMATORY-BOWEL-DISEASE
  • CYCLOOXYGENASE-2 EXPRESSION
  • RISK-FACTORS
  • NSAID USE
  • CANCER
  • ADENOMAS
  • CARCINOMAS
  • COX-2
  • CHEMOPREVENTION
  • METAANALYSIS

Fingerprint

Dive into the research topics of 'Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis'. Together they form a unique fingerprint.

Cite this